Open Access
Issue
J Extra Corpor Technol
Volume 38, Number 1, March 2006
Page(s) 27 - 32
DOI https://doi.org/10.1051/ject/200638027
Published online 15 March 2006
  1. Gravlee GP, Davis RF, Kurusz M, Utley JR. Cardiopulmonary Bypass Principles and Practices. Philadelphia, PA: Lippincott Williams and Wilkins; 2000. [Google Scholar]
  2. Rubens FD. Cardiopulmonary bypass technology transfer: musings of a cardiac surgeon. J Biomater Sci Polymer Educ. 2002;13:485–99. [CrossRef] [PubMed] [Google Scholar]
  3. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg. 1990;49:32–4. [CrossRef] [Google Scholar]
  4. Wenger RK, Lukasiewicz H, Mikuta S, Niewiarowski S, Edmunds LHJr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. Ann Thorac Surg. 1989;97:235–9. [CrossRef] [Google Scholar]
  5. Defraigne JO, Pincemail J, Dekoster G, et al. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery. Ann Thorac Surg. 2000;70:2075–81. [CrossRef] [Google Scholar]
  6. Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility. Ann Thoracic Surg. 1998;65:1342–7. [CrossRef] [Google Scholar]
  7. Ninomiya M, Miyaji K, Takamoto S. Influence of PMEA-coated bypass circuits on perioperative inflammatory response. Ann Thorac Surg. 2003;75:913–7. [CrossRef] [Google Scholar]
  8. Ikuta T, Fujii H, Shibata T, et al. A new poly-2-methoxyethylacrylate-coated cardiopulmonary bypass circuit possesses superior platelet preservation and inflammatory suppression efficacy. Ann Thorac Surg. 2004;77:1678–83. [CrossRef] [Google Scholar]
  9. Suhara H, Sawa Y, Nishimura M, et al. Efficacy of a new coating material PMEA, for cardiopulmonary bypass circuits in a porcine model. Ann Thorac Surg. 2001;71:1603–8. [CrossRef] [Google Scholar]
  10. Vijay V, McCusker K. Recent advances in biocompatible surface-modifying additives for cardiopulmonary bypass. Perfusion. 2003;18:41–5. [CrossRef] [PubMed] [Google Scholar]
  11. Aldea GS. Heparin bonded circuits decrease thromboembolitic complications and improve outcomes in patients undergoing coronary artery bypass graft surgery. Semin Cardiothorac Vasc Anesth. 1999;3:9–16. [CrossRef] [Google Scholar]
  12. Rubens FD, Labow RS, Lavillee GR, et al. Hematologic evaluation of cardiopulmonary bypass circuits prepared with a novel block copolymer. Ann Thorac Surg. 1999;67:689–96. [CrossRef] [Google Scholar]
  13. Anzai T, Okumura A, Kawaura M, et al. Evaluation of the biocompatibility of an in vitro study test using poly2-methoxyethylacrylate coated oxygenator. Jpn J Artif Organs. 2000;29:73–9. [Google Scholar]
  14. Tanaka M, Motomura T, Kawada M, et al. Blood compatible aspects of poly (2-methoyethylacylate) (PMEA) relationship between protein absorption and platelet adhesion on PMEA surface. Biomaterials. 2000;21:1471–81. [CrossRef] [PubMed] [Google Scholar]
  15. Saito N, Motoyama S, Sawamoto J. Effects of new polymer-coated extracorporeal circuits on biocompatibility during cardiopulmonary bypass. Artif Organs. 2000;24:547–54. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.